Scinai Immunotherapeutics (SCNI) Change in Cash (2018 - 2026)

Scinai Immunotherapeutics has reported Change in Cash for 9 years, with the latest figure at $1.3 million in Q1 2026.

• Quarterly Change in Cash rose 237.74% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (up 133.14% YoY) and the FY2025 annual result came in at -$284000.0, up 90.26% from the prior year.
• Change in Cash climbed to $1.3 million in Q1 2026 per SCNI's latest filing, from -$18000.0 in the prior quarter.
• Over five years, Change in Cash peaked at $5.8 million in Q4 2022 and troughed at -$9.3 million in Q2 2022.
• A 5-year average of -$1.4 million and a median of -$1.5 million in 2023 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2025 and 2026: Change in Cash sank 2050.0% in 2025, then soared 237.74% in 2026.
• Over 5 years, Change in Cash stood at $5.8 million in 2022, then tumbled by 125.56% to -$1.5 million in 2023, then surged by 162.86% to $926000.0 in 2024, then plunged by 101.94% to -$18000.0 in 2025, then surged by 7338.89% to $1.3 million in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered $1.3 million, -$18000.0, and -$946000.0 for Q1 2026, Q2 2025, and Q1 2025 respectively.